Multiple immune and metabolic proteins

The term 'Multiple immune and metabolic proteins' does not refer to a single, specific therapeutic target but rather describes a broad category of proteins involved in the field of immunometabolism. Immunometabolism involves the integration of metabolic and inflammatory pathways, where proteins such as cytokines, adipokines, and intracellular enzymes play dual roles in regulating energy balance and immune cell function (Nature Reviews Immunology, 2017). Because this term encompasses a wide variety of distinct molecular entities, it lacks the specificity required for a canonical drug target, which is typically defined as a single protein or nucleic acid involved in a disease process (NIH/NCATS). In pharmacological research, drugs may be described as modulating multiple proteins to achieve a systemic effect, but these proteins must be individually identified for structured data analysis. Consequently, this entry is classified as incorrect due to being overly broad and lacking a unique molecular identity. Effective therapeutic intervention requires the identification of specific targets within these pathways, such as Janus kinases or PPAR receptors, rather than a collective group.

Not applicable